Introduction Antipsychotic polypharmacy (APP) remains a contentious practice in the treatment of schizophrenia. While some clinicians advocate for combining antipsychotics to address persistent symptoms or…
Introduction: The Need for Multi-system Biomarkers in MDD Major Depressive Disorder (MDD) remains a leading cause of disability worldwide, with suicide risk representing a critical…
Introduction: A Misunderstood Medicine, A Modern Approach For many people living with depression, the path to relief can be winding and uncertain. Traditional antidepressants help…